Menu
GeneBe

PRICKLE1

prickle planar cell polarity protein 1, the group of Prickle planar cell polarity proteins|LIM domain containing

Basic information

Region (hg38): 12:42456756-42590355

Links

ENSG00000139174NCBI:144165OMIM:608500HGNC:17019Uniprot:Q96MT3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Unverricht-Lundborg syndrome (Supportive), mode of inheritance: AR
  • epilepsy, progressive myoclonic, 1B (Strong), mode of inheritance: AR
  • epilepsy (Disputed Evidence), mode of inheritance: AD
  • progressive myoclonus epilepsy (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Epilepsy, progressive myoclonic, 1BAD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic15634728; 15642921; 16376507; 18976727; 21276947
As with other forms of epilepsy, optimal seizure control is advantageous, and genetic diagnosis may aid with medication selection

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRICKLE1 gene.

  • Epilepsy, progressive myoclonic, 1B (466 variants)
  • not provided (113 variants)
  • Inborn genetic diseases (82 variants)
  • not specified (64 variants)
  • Intellectual disability (3 variants)
  • Childhood epilepsy with centrotemporal spikes (3 variants)
  • PRICKLE1-related condition (2 variants)
  • Arthrogryposis multiplex congenita;Fetal akinesia deformation sequence 1 (1 variants)
  • Seizure (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRICKLE1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
126
clinvar
3
clinvar
132
missense
2
clinvar
298
clinvar
2
clinvar
3
clinvar
305
nonsense
2
clinvar
2
start loss
1
clinvar
1
frameshift
9
clinvar
9
inframe indel
4
clinvar
4
splice donor/acceptor (+/-2bp)
0
splice region
10
8
18
non coding
6
clinvar
44
clinvar
24
clinvar
74
Total 0 2 323 172 30

Variants in PRICKLE1

This is a list of pathogenic ClinVar variants found in the PRICKLE1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-42459195-C-T Epilepsy, progressive myoclonic, 1B Uncertain significance (Jun 14, 2016)308690
12-42459213-CTT-C Epilepsy, progressive myoclonic, 1B Uncertain significance (Jun 14, 2016)308691
12-42459256-GT-G Epilepsy, progressive myoclonic, 1B Uncertain significance (Jun 14, 2016)308692
12-42459548-A-G Benign (Jun 14, 2018)1293941
12-42459667-C-T Epilepsy, progressive myoclonic, 1B Uncertain significance (Jun 14, 2016)308699
12-42459718-A-G Benign (Jun 14, 2018)1291049
12-42459818-A-G Epilepsy, progressive myoclonic, 1B Likely benign (Dec 02, 2023)1086873
12-42459830-G-C Epilepsy, progressive myoclonic, 1B Likely benign (Aug 12, 2022)750892
12-42459832-C-T Epilepsy, progressive myoclonic, 1B Uncertain significance (Oct 17, 2022)469510
12-42459833-C-T Epilepsy, progressive myoclonic, 1B Likely benign (Apr 14, 2020)1091262
12-42459840-C-A Epilepsy, progressive myoclonic, 1B Uncertain significance (Mar 14, 2022)1514589
12-42459846-T-C Epilepsy, progressive myoclonic, 1B Uncertain significance (Aug 28, 2021)1377929
12-42459847-T-G Epilepsy, progressive myoclonic, 1B Uncertain significance (Aug 26, 2021)1038526
12-42459859-T-C Epilepsy, progressive myoclonic, 1B Uncertain significance (Jun 17, 2020)1044988
12-42459866-C-T Epilepsy, progressive myoclonic, 1B • not specified Likely benign (Dec 19, 2023)416260
12-42459874-C-T Epilepsy, progressive myoclonic, 1B Uncertain significance (Jul 16, 2022)537239
12-42459880-G-C Epilepsy, progressive myoclonic, 1B Uncertain significance (Jul 17, 2023)1041337
12-42459882-G-A Epilepsy, progressive myoclonic, 1B Uncertain significance (Jul 26, 2022)1422114
12-42459883-G-T Epilepsy, progressive myoclonic, 1B Uncertain significance (Aug 31, 2021)939684
12-42459885-G-A Epilepsy, progressive myoclonic, 1B Uncertain significance (Jan 18, 2022)2417269
12-42459892-G-C Epilepsy, progressive myoclonic, 1B Uncertain significance (Apr 01, 2021)1415945
12-42459899-T-A Epilepsy, progressive myoclonic, 1B Likely benign (Jul 13, 2023)2742883
12-42459899-T-C Epilepsy, progressive myoclonic, 1B Likely benign (Aug 10, 2023)2163705
12-42459901-G-A not specified • Epilepsy, progressive myoclonic, 1B Conflicting classifications of pathogenicity (Jan 16, 2024)206656
12-42459902-T-A Epilepsy, progressive myoclonic, 1B Likely benign (Feb 14, 2022)1123135

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRICKLE1protein_codingprotein_codingENST00000455697 7132018
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.00000961125737081257450.0000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.833484580.7590.00002685482
Missense in Polyphen102176.960.576412053
Synonymous0.9051621770.9140.00001071552
Loss of Function5.47136.80.02710.00000197445

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001210.000119
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00003530.0000352
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the planar cell polarity pathway that controls convergent extension during gastrulation and neural tube closure. Convergent extension is a complex morphogenetic process during which cells elongate, move mediolaterally, and intercalate between neighboring cells, leading to convergence toward the mediolateral axis and extension along the anteroposterior axis. Necessary for nuclear localization of REST. May serve as nuclear receptor. {ECO:0000269|PubMed:21901791}.;
Disease
DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:21901791}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Wnt signaling pathway - Homo sapiens (human);Wnt Signaling Pathway;Signaling by WNT;Signal Transduction;Asymmetric localization of PCP proteins;PCP/CE pathway;Beta-catenin independent WNT signaling (Consensus)

Recessive Scores

pRec
0.146

Intolerance Scores

loftool
0.0772
rvis_EVS
-0.29
rvis_percentile_EVS
33.47

Haploinsufficiency Scores

pHI
0.822
hipred
Y
hipred_score
0.786
ghis
0.522

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.632

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prickle1
Phenotype
vision/eye phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
prickle1a
Affected structure
hepatocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
neural tube closure;protein import into nucleus;positive regulation of protein ubiquitination;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;aorta development;negative regulation of transcription, DNA-templated;Wnt signaling pathway, planar cell polarity pathway;coronary vasculature development;negative regulation of canonical Wnt signaling pathway;negative regulation of cardiac muscle cell myoblast differentiation
Cellular component
nucleus;cytosol;nuclear membrane
Molecular function
protein binding;zinc ion binding